• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Techfields Taps Medidata to Power Mobile Health Stroke Study

by HITC Staff 09/07/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Medidata Clinical Cloud

Techfields Pharma, a China-based pharmaceutical company has selected Medidata Clinical Cloud, a provider of cloud-based solutions for clinical research to power a Phase II Ischemic mobile health stroke study. Through the collaboration, Medidata and Techfields will leverage Medidata’s cloud technology platform to optimize trial processes and gather new insights on treatment efficacy and patients’ quality of life. 

 

“Cloud and mobile health technologies offer new channels for maximizing the value of clinical data, and we believe they will play an increasingly important role in our ability to bring vital new medicines to patients,” said Dr. Chongxi Yu, Techfields’ founder and president in a statement. “Using the Medidata platform, our research teams can more quickly access richer, more complete clinical datasets while gaining valuable insight into patient well-being and disease progression. This is a key focus of our R&D strategy, as we pursue promising drug candidates with the potential to help people live longer, healthier lives.”

Mobile Health Stroke Study Details

Headquartered in Suzhou, China, Techfields is a clinical-stage pharmaceutical company focused on the development of novel medicines for inflammatory, autoimmune, cardiovascular, metabolic and aging-related diseases, as well as depression. To streamline trial operations and improve data quality in its upcoming Phase II Ischemic Stroke study, Techfields is adopting Medidata’s unified, cloud-based solutions for electronic data capture (Medidata Rave®), randomization and trial supply management (Medidata Balance®) and mHealth (Medidata Patient Cloud).

Previous Partnerships

Medidata SensorLink is currently being used by Techfields to capture continuous data from the Garmin vívofit® 3 activity trackers measuring study participants’ movement and mobility. Techfields is also using Medidata’s Patient Cloud ePRO (electronic patient-reported outcome) app—easily accessible via a smartphone or tablet—to allow stroke patients participating in the trial to complete questionnaires on quality-of-life, disease state, and response to treatment using an Apple® iPad®. Data from the mHealth solutions is integrated into the secure, regulatory-compliant environment of the Medidata Clinical Cloud.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Medidata, Techfields Pharma

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |